Skip to main content

Teveten Side Effects

Generic name: eprosartan

Medically reviewed by Drugs.com. Last updated on Mar 16, 2023.

Note: This document contains side effect information about eprosartan. Some dosage forms listed on this page may not apply to the brand name Teveten.

Applies to eprosartan: oral tablet.

Warning

Oral route (Tablet)

Drugs that act on the renin-angiotensin system can cause injury or death to the developing fetus when used during the second and third trimesters. When pregnancy is confirmed, discontinue treatment immediately.

Serious side effects of Teveten

Along with its needed effects, eprosartan (the active ingredient contained in Teveten) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.

Check with your doctor immediately if any of the following side effects occur while taking eprosartan:

Less common

Rare

Other side effects of Teveten

Some side effects of eprosartan may occur that usually do not need medical attention. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.

Check with your health care professional if any of the following side effects continue or are bothersome or if you have any questions about them:

Less common or rare

For Healthcare Professionals

Applies to eprosartan: oral tablet.

General

The most common adverse reactions were headache and unspecific gastrointestinal complaints.[Ref]

Nervous system

Very common (10% or more): Headache (up to 11%)

Common (1% to 10%): Dizziness

Frequency not reported: Ataxia, migraine, neuritis, paresthesia, somnolence, tremor, vertigo, tinnitus[Ref]

Gastrointestinal

Common (1% to 10%): Unspecific gastrointestinal complaints, abdominal pain, diarrhea, dyspepsia

Frequency not reported: Constipation, dry mouth, esophagitis, flatulence, gastritis, gastroenteritis, gingivitis, nausea, periodontitis, toothache, vomiting[Ref]

Respiratory

Common (1% to 10%): Rhinitis, upper respiratory tract infection, pharyngitis, coughing, sinusitis, dyspnea, bronchitis

Frequency not reported: Asthma, epistaxis[Ref]

Other

Common (1% to 10%): Asthenia, injury, chest pain, fatigue, pain

Uncommon (0.1% to 1%): Facial edema

Frequency not reported: Substernal chest pain, peripheral edema, fever, influenza-like symptoms, malaise[Ref]

Musculoskeletal

Common (1% to 10%): Myalgia, arthralgia, back pain

Frequency not reported: Rigors, creatine phosphokinase increased, arthritis, arthritis aggravated, arthrosis, skeletal pain, tendinitis, leg cramps[Ref]

Cardiovascular

Common (1% to 10%): Palpitation, dependent edema

Uncommon (0.1% to 1%): Hypotension

Frequency not reported: Hot flushes, angina pectoris, bradycardia, ECG abnormal, ECG specific abnormal, extrasystoles, atrial fibrillation, tachycardia, peripheral ischemia[Ref]

Hematologic

Common (1% to 10%): Neutrophils 1500/mm3 or less

Uncommon (0.1% to 1%): Hemoglobin decreased greater than 20%, WBC count of 3000/mm3 or less, platelets 100 x 10(9)/L or less

Frequency not reported: Anemia, leukopenia[Ref]

Metabolic

Common (1% to 10%): Hypertriglyceridemia

Uncommon (0.1% to 1%): Potassium 5.6 mmol/L or greater

Frequency not reported: Alcohol intolerance, anorexia, diabetes mellitus, gout, hypercholesterolemia, hyperglycemia, hyperkalemia, hypokalemia, hyponatremia[Ref]

Dermatologic

Common (1% to 10%): Allergic skin reactions

Uncommon (0.1% to 1%): Angioedema

Frequency not reported: Purpura, eczema, furunculosis, pruritus, rash, maculopapular rash, sweating increased[Ref]

Immunologic

Common (1% to 10%): Viral infection

Uncommon (0.1% to 1%): Hypersensitivity

Frequency not reported: Herpes simplex, otitis externa, otitis media[Ref]

Renal

Common (1% to 10%): BUN increased

Uncommon (0.1% to 1%): Creatinine increased

Frequency not reported: Renal calculus

Postmarketing reports: Impaired renal function, renal failure[Ref]

Genitourinary

Common (1% to 10%): Urinary tract infection

Frequency not reported: Glycosuria, albuminuria, cystitis, hematuria, micturition frequency, polyuria, urinary incontinence[Ref]

Psychiatric

Common (1% to 10%): Depression

Frequency not reported: Anxiety, insomnia, nervousness[Ref]

Hepatic

Uncommon (0.1% to 1%): ALT greater than 3.5 times the upper limit of normal

Frequency not reported: Serum glutamic oxaloacetic transaminase (SGOT) increased, serum glutamic pyruvic transaminase (SGPT) increased, ALT increased, AST increased, alkaline phosphatase increased[Ref]

Ocular

Frequency not reported: Conjunctivitis, vision abnormal, xerophthalmia[Ref]

References

1. Product Information. Teveten (eprosartan). SmithKline Beecham. 2001;PROD.

2. Cerner Multum, Inc. UK Summary of Product Characteristics.

3. Cerner Multum, Inc. Australian Product Information.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Some side effects may not be reported. You may report them to the FDA.